Scott Delp
Scott Delp is the James H. Clark Professor, Founding Chairman of the Department of Bioengineering at Stanford, and Director of the National Center for Simulation in Rehabilitation Research. Delp transformed the field of biomechanics by creating highly accurate computer models of musculoskeletal structures and providing them to researchers worldwide using a software system (OpenSim) that he and his team developed. Delp invented fundamental technology for surgical navigation that is now in wide clinical use. Together with Mark Schnitzer and their students, Delp developed novel microendoscopes that allow realtime in vivo imaging of human muscle microstructure. Together with Karl Deisseroth and their students, Delp pioneered the use of optogenetics to control activity in the peripheral nervous system leading to important inventions for treating paralysis, spasticity and pain.
Cédric Hutchings
Cedric Hutchings is Vice President of Digital Health at Nokia Technologies. Prior to his current position, Cedric was co-founder and CEO of Withings, a consumer electronics company developing smart products to help people around the world easily manage their health and well-being. Withings was founded in 2008 in France, and released the first WiFi smart scale in 2009. Since then, Withings broadened its range of products to include various fitness and sleep trackers, a wireless blood pressure monitor and a WiFi thermometer, amongst other innovative products. Withings was acquired by Nokia Technologies in May 2016.
Armed with an engineering degree from Ecole Centrale and a Masters from Massachusetts Institute of Technology (MIT), Cédric first worked as a product manager at Inventel, overseeing the launch of residential wireless gateways. He then joined Thompson as Marketing Director for Domestic Products. Driving the development of Nokia Technologies’ life-changing products, his vision is to reinvent our relationship with health, empowering people to overcome any fears or barriers associated with it and help them regain control.
Joy Ku
Joy Ku is the Director for Simbios, the National Center for Physics-Based Simulations of Biological Structures. The Center is funded by the NIH. In addition to the research we conduct on a diverse range of structures — from molecules to musculoskeletal systems — the Center provides both software and training opportunities. We also support Simtk.org (http://simtk.org), a web portal for collaborating on and publicly sharing biocomputational projects, and the Biomedical Computation Review magazine.
Spyros Papapetropoulous
Spyros is a recognized researcher, an experienced biopharmaceutical and healthcare executive and a digital health expert. He is currently Vice President and Global Head of Neurodegeneration, Movement Disorders and Clinical Research Transformation at TEVA Pharmaceuticals.
Prior joining TEVA he held positions of increasing responsibility at Biogen’s Experimental Neurology Unit, Allergan’s Global Medical Affairs and Pfizer’s Neuroscience Research Unit. He has filed multiple INDs and has overseen a wide spectrum of pharmaceutical development programs leading to successful regulatory filings and new product launches. He has led in-licencing efforts and corporate partnerships with profit, non-profit organizations and academic institutions. Spyros has proven people skills, is a strong leader focused on innovation, organizational excellence and efficiency.
Spyros is a board-certified Neurologist and a Movement Disorders specialist trained at the University of Patras in Greece and the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK. He holds appointments as Consultant with Massachusetts General Hospital and Voluntary Professor of Neurology with the University of Miami, Miller School of Medicine.
Spyros’s primary academic interests remain in -omics and digital health. He has authored impactful peer-reviewed publications, book chapters, presented and chaired scientific meetings since 1998. Spyros is currently co-chairing the International Parkinson’s Disease and Movement Disorders Society’s (IPMDS) Taskforce on Technology and is a member of various US government and non-profit committees on healthcare and biomedical research innovation.
Bakul Patel
Bakul Patel is Associate Director for Digital Health, at the Center for Devices and Radiological Health (CDRH), at the Food and Drug Administration (FDA). Mr. Patel leads regulatory policy and scientific efforts at the Center in areas related to emerging and converging areas of medical devices, wireless and information technology. This includes responsibilities for mobile health, health information technology, cyber security, medical device interoperability, and medical device software.
Mr. Patel is the FDA liaison between the Federal Communications Commission (FCC) and the Office of the National Coordinator (ONC). Since its inception in 2013, Bakul chairs the International Medical Device Regulators Forum (IMDRF) “software as a medical device” working group, a global harmonization effort.
Before joining FDA, Mr. Patel held key leadership positions working in the telecommunications industry, semiconductor capital equipment industry, wireless industry and information technology industry. His experience includes Lean Six Sigma, creating long and short-term strategy, influencing organizational change, modernizing government systems, and delivering high technology products and services in fast-paced, technology-intensive organizations.
Mr. Patel earned an MS in Electronic Systems Engineering from the University of Regina, Canada, and an MBA in International Business from The Johns Hopkins University.
David Shaywitz
About the Moderator: Dr. Shaywitz is chief medical officer at DNAnexus, and holds an adjunct appointment as Visiting Scientist in the Department of Biomedical Informatics at Harvard Medical School. He has a decade of experience in the life science industry, with experience in R&D, strategy, and commercial operations through his work at Merck, the Boston Consulting Group, and Theravance. Dr. Shaywitz received his MD/PhD from Harvard and MIT, and trained in internal medicine and endocrinology at the Massachusetts General Hospital. He is co-author, with Lisa Suennen, of “Tech Tonics: Can Passionate Entrepreneurs Heal Healthcare With Technology?”, and writes regularly about entrepreneurial innovation in medicine for Forbes.
Ida Sim
Ida Sim, MD, PhD is a primary care physician, informatics researcher, and entrepreneur. She is a Professor of Medicine at the University of California, San Francisco, where she co-directs Informatics and Research Innovation at UCSF’s Clinical and Translational Sciences Institute, and is Director of Digital Health for the Division of General Internal Medicine. Dr. Sim is a global leader in the technology and policy of large-scale health data sharing.
She is a co-founder of Open mHealth, a non-profit organization that is breaking down barriers to mobile health app and data integration through an open software architecture. Open mHealth is an official working group of the IEEE Standards Association and soon to be a global IEEE standard. Dr. Sim has multiple grants from NIH, NSF, and AHRQ on mobile health methodology and digital health for primary care. In 2019, she co-developed CommonHealth, an open source software suite bringing to the Android ecosystem the equivalent of Apple Health’s ability to access and share EHR data.
Dr. Sim is also co-founder of Vivli, the world’s largest data sharing platform for participant-level clinical trial data. In 2005, she was the founding Project Coordinator of the World Health Organization’s International Clinical Trials Registry Platform, where she led the establishment of the first global policy on clinical trial registration.
Dr. Sim has served on multiple advisory committees on health information infrastructure for clinical care and research, including committees of the National Research Council and National Academy of Medicine. She is a recipient of the United States Presidential Early Career Award for Scientists and Engineers (PECASE), a Fellow of the American College of Medical Informatics, and a member of the American Society for Clinical Investigation.
Michael Snyder
Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and proteomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics.
He has also combined different state-of–the-art “omics” technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. Dr. Snyder recently published a paper demonstrating the ability to utilize wearable devices to identify abnormal physiological signals, in this case arising from the onset of Lyme disease.
Dr. Snyder is a cofounder of several biotechnology companies, including Protometrix (now part of Life Technologies), Affomix (now part of Illumina), Excelix, and Personalis, and he presently serves on the board of a number of companies.
Laura Wilt
Laura Wilt is the System Vice President and Chief Information Officer of Ochsner Health System. Ms. Wilt joined Ochsner in 2013 after several years leading a boutique consulting firm that specializes in Epic. Prior to that, Ms. Wilt worked for Epic, based out of Verona, Wisconsin, as an Implementation Executive.
In her work with Ochsner, Ms. Wilt led the team that has had a significant impact in implementing, supporting, scaling and optimizing Epic and over 100 departmental systems for both Ochsner Health System and the Ochsner Health Network. To date, that team has implemented Epic at 14 hospitals and more than 100 clinic locations. Through that experience, all of Ochsner’s hospitals have achieved HIMSS Level 7 designation, and Ochsner Health System received the CHIME/AHA Transformational Leadership Award in 2015.
Ms. Wilt earned both her undergraduate and Masters of Business Administration from Tulane University. She is a member of CHIME, the College of Healthcare Information Management Executives, and has earned the designation of a being a Certified Healthcare CIO.
Marta Gaia Zanchi
Marta Gaia Zanchi, PhD, is the Founder and Managing Director of Medinnovo, as well as a Lecturer with Stanford University’s School of Medicine, Department of Surgery. Under Medinnovo, Dr. Zanchi provides mentorship in advisory positions to startups and entrepreneurial teams of students and alumni entrepreneurs from Stanford University and other schools. As a Lecturer at Stanford University she co-directs “Biodesign for Mobile Health,” an entrepreneurial class where students learn the principles of creating innovation in Mobile Health, and participates to Biodesign’s programmatic activities as a member of the Biodesign Leadership Group. Dr. Zanchi is also a third-year mentor at StartX MED, a healthcare-focused student startup accelerator designed and developed to provide a premier entrepreneurial experience for Stanford students.
Most recently in the years 2012 to 2014, Dr. Zanchi was the Chief Executive Officer of RenovoRx, Inc, which she helped transition from concept phase to clinical trials and for which she raised close to $2M in two rounds of funding. In 2012 she was a resident with The Angels Forum, where she helped identify and screen life science companies and learned the fundamentals of the angel funding process. In the same years she co-authored the InHealth study “A Comprehensive Analysis of the FDA 510(k) Process,” led by investigators John Linehan, PhD, and Jan Pietzsch, PhD, applying her experience working as Medical Device Fellow, Reviewer and Electrical Engineer with the U.S. Food and Drug Administration (FDA).
Dr. Zanchi’s core expertise is in medical device development and regulation, wireless semiconductors and systems, medical imaging systems, cardiovascular devices, mobile/digital health, business development, fundraising, and product management strategies. Dr. Zanchi is a top graduate in biomedical engineering and electrical engineering from Politecnico Di Milano (Italy) and Stanford University. She holds a certificate in entrepreneurship and an award from the Stanford Graduate School of Business at Stanford University.